TotalMarketCap

Tango Therapeutics

TNGXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.525 B

$20.91 -9.81%

Close of 6 Nov 2026

As of 6 Nov 2026, Tango Therapeutics (TNGX) has a market capitalization of $3.52B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$62.4M

#2645 by revenue

Earnings

-$101.6M

Loss-making

Shares outstanding

168,610,367

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #63Organon & Co.OGN$3.63B
  2. #64AbCellera BiologicsABCL$3.60B
  3. #65Tango TherapeuticsTNGX$3.52B
  4. #66Disc MedicineIRON$3.49B
  5. #67Amylyx PharmaceuticalsAMLX$3.48B

What if Tango Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$167,468.20

Per share 8,011× higher

Bitcoin $1.53T

$9,061.41

Per share 433× higher

Apple $5.02T

$29,747.77

Per share 1,423× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Tango Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.